-
Stiripentol and Lactate: Designing Better LDH Studies
2026-09-27
Explore Stiripentol as an LDH inhibitor through an assay-design lens that connects neuronal lactate metabolism with emerging evidence on histone lactylation. Learn how to separate demonstrated findings from cross-domain hypotheses and build more interpretable experiments.
-
Reserpine N1867: Solubility, Storage, and QC
2026-09-26
Reserpine N1867 provides a defined research reagent for workflows studying neurotransmitter depletion, antihypertensive mechanisms, and neuropharmacology. Its limited aqueous solubility makes solvent selection and fresh preparation important; it is for research use only, not diagnostic or medical use.
-
Tricine-SDS-PAGE Electrophoresis System Guide
2026-09-25
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is designed to improve separation of low-molecular-weight proteins and peptides that may be poorly resolved by conventional Tris-SDS-PAGE. It is for research protein electrophoresis, including denaturing or non-denaturing workflows when the sample and buffer conditions are configured accordingly; it is not for diagnostic or medical use.
-
AZD-3463: Translational Strategy for ALK-Driven Cancer
2026-09-25
A translational perspective on using AZD-3463 to probe ALK and IGF1R signaling in neuroblastoma, design mutation-aware experiments, and evaluate combination strategies—while keeping preclinical evidence, assay reproducibility, and clinical relevance in clear view.
-
Reserpine (N1867): Practical Lab Workflow
2026-09-24
Reserpine (N1867) provides a characterized research reagent for controlled neurotransmitter depletion, antihypertensive mechanism studies, and neuropharmacology workflows. Its poor water and ethanol solubility calls for deliberate solvent selection and fresh working solutions; it is not intended for diagnostic, clinical, therapeutic, or veterinary use.
-
Halazone: Interpreting Redox and Nerve Evidence
2026-09-24
Halazone is an antimicrobial sulfonamide derivative used in water-disinfection research, but its oxidant chemistry also creates a striking experimental effect on sodium-current inactivation. This article connects those findings while clarifying what they do—and do not—establish for assay design and antimicrobial resistance research.
-
AZD3463 Workflows for ALK-Driven Cancer Research
2026-09-24
Build practical neuroblastoma studies around AZD3463, a dual ALK/IGF1R inhibitor, with workflows that connect pathway readouts to apoptosis and treatment response. The guide also shows how to use cross-talk findings from a breast cancer study to sharpen assay design—without assuming those findings establish AZD3463 activity in breast cancer.
-
Nintedanib (BIBF 1120): An ATRX-Aware Strategy
2026-09-23
Nintedanib (BIBF 1120) offers a mechanistically rich way to study VEGFR, FGFR, and PDGFR signaling. This article connects its triple-target profile with ATRX-aware glioma research and translational assay design.
-
TPA, PKC–ERK Signaling, and Translational Strategy
2026-09-22
12-O-tetradecanoyl phorbol-13-acetate (TPA) is more than a pathway activator: it is a strategic perturbation tool for resolving PKC–ERK kinetics, validating signal-transduction assays, and interrogating tumor-promoting biology. This article connects TPA-enabled ERK/MAPK pathway activation with translational study design, while defining the opportunities and limitations of extending oncology findings into macrophage and immune research.
-
Cyclic di-GMP: From Biofilm Persistence to STING
2026-09-22
Cyclic di-GMP is an intracellular second messenger whose biological meaning depends on timing, compartment, and assay context. This article connects its antitoxin role in early biofilm development with STING-focused immune modulation research while translating the findings into better experimental decisions.
-
Predicting Major Bleeding During Extended Anticoagulation
2026-09-21
This prospective multinational cohort study evaluated bleeding-risk prediction in patients with unprovoked or weakly provoked venous thromboembolism receiving extended anticoagulation. Modified ACCP, VTE-BLEED, and HAS-BLED scores identified higher-risk patients, while the simpler CHAP model used continuous creatinine, hemoglobin, age, and antiplatelet-use variables and showed comparable discrimination, although external validation remains necessary.
-
Ranolazine: A Mechanistic Roadmap for Translation
2026-09-21
Ranolazine offers a useful translational model for connecting ion handling, myocardial relaxation, and metabolic efficiency. By pairing its cardiac mechanism with lessons from HBV–TBK1 research, this article presents a rigorous framework for designing cardiac ischemia and liver metabolism assays without overstating cross-domain evidence.
-
SETD7 Depletion Drives White Fat Browning in Obesity
2026-09-20
A 2026 Cell Death & Differentiation study identifies SETD7 as a negative regulator of inguinal white adipose tissue thermogenesis. Genetic SETD7 depletion enhanced beige-fat activation through an Adcy7–Sirt1–CREB1 pathway, increased energy expenditure, and improved resistance to high-fat-diet-induced metabolic dysfunction in mice.
-
X-Gal Workflows for Cloning and Reporter Assays
2026-09-19
Build more reliable blue-white colony screening workflows with X-Gal, from stock preparation and plate design to clone confirmation. The same chromogenic chemistry can also support engineered β-galactosidase reporter studies, provided its qualitative readout is interpreted alongside molecular and transcriptomic assays.
-
Reserpine (N1867): Lab Workflow Guide
2026-09-19
Reserpine (SKU N1867) provides a characterized research compound for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide focuses on preparation, storage, and quality control; the material is for research use only and should not be used for diagnostic, therapeutic, clinical, or veterinary applications.